These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 10539663)

  • 61. Too many cooks. FTC, Justice Department call consent decrees ineffective.
    Taylor M
    Mod Healthc; 2004 Nov; 34(44):16. PubMed ID: 15554338
    [No Abstract]   [Full Text] [Related]  

  • 62. Say uncle. FTC fights to control hospital mergers.
    Neil R
    Mater Manag Health Care; 2003 Apr; 12(4):16-9. PubMed ID: 12854202
    [No Abstract]   [Full Text] [Related]  

  • 63. Special report on antitrust. New antitrust merger guidelines.
    Enders RJ
    Health Care Law Newsl; 1992 Aug; 7(8):13-7. PubMed ID: 10121309
    [No Abstract]   [Full Text] [Related]  

  • 64. Changing antitrust prospects for hospital mergers.
    O'Malley S
    Health Syst Lead; 1997 Jan; 4(1):4-12. PubMed ID: 10164539
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Economic analysis in health care antitrust.
    Vita MG; Langenfeld J; Pautler P; Miller L
    J Contemp Health Law Policy; 1991; 7():73-115. PubMed ID: 10111250
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Health care alliances--good medicine for an ailing health care industry, or antitrust illnesses to fence in?
    Sander NL
    Spec Law Dig Health Care Law; 1997 Dec; (226):9-49. PubMed ID: 10175045
    [No Abstract]   [Full Text] [Related]  

  • 67. Recent court decisions expand merger possibilities.
    O'Hare PK
    Healthc Financ Manage; 1996 Apr; 50(4):18-9. PubMed ID: 10156592
    [No Abstract]   [Full Text] [Related]  

  • 68. Not so fast. FTC decided deal bad for competition: Scott & White.
    Blesch G
    Mod Healthc; 2009 Nov; 39(46):18. PubMed ID: 20050236
    [No Abstract]   [Full Text] [Related]  

  • 69. FTC reconsiders case against Missouri deal.
    Scott L
    Mod Healthc; 1995 Feb; 25(9):5. PubMed ID: 10140282
    [No Abstract]   [Full Text] [Related]  

  • 70. Point/counterpoint: the proposed Grand Rapids merger.
    O'Malley S
    Health Syst Lead; 1997 Jan; 4(1):13-6. PubMed ID: 10164536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FTC requests more data from MCA, Columbia/HCA.
    Lutz S
    Mod Healthc; 1994 Aug; 24(33):14. PubMed ID: 10135511
    [No Abstract]   [Full Text] [Related]  

  • 72. Analysis probes risk of antitrust suit.
    Nickles P; Tucker G; Brown M
    Mod Healthc; 1982 Dec; 12(12):104, 108-9. PubMed ID: 10257600
    [No Abstract]   [Full Text] [Related]  

  • 73. Injunction of hospital merger dissolved.
    Health Care Law Mon; 1999 Sep; ():27-8. PubMed ID: 10623063
    [No Abstract]   [Full Text] [Related]  

  • 74. Merging hospitals learn costs of fighting antitrust challenge from Justice Dept.
    Burda D
    Mod Healthc; 1990 Mar; 20(11):32. PubMed ID: 10103903
    [No Abstract]   [Full Text] [Related]  

  • 75. Hospitals caught between pressure to merge and risk of antitrust litigation.
    Hoff JS; Ngau TA
    Mod Healthc; 1987 Jul; 17(15):55. PubMed ID: 10282808
    [No Abstract]   [Full Text] [Related]  

  • 76. No deal? Columbia-Alexian Brothers swap hits antitrust snag.
    Shinkman R
    Mod Healthc; 1998 Dec; 28(49):32. PubMed ID: 10187540
    [No Abstract]   [Full Text] [Related]  

  • 77. Hospital mergers and the antitrust laws: major roadblock or minor constraint.
    Fried JM; Sneed JH
    Hosp Health Serv Adm; 1984; 29(3):50-8. PubMed ID: 10266559
    [No Abstract]   [Full Text] [Related]  

  • 78. Antitrust considerations for hospital mergers: market definition and market concentration.
    Wilder RP; Jacobs P
    Adv Health Econ Health Serv Res; 1987; 7():245-62. PubMed ID: 10291982
    [No Abstract]   [Full Text] [Related]  

  • 79. Columbia deal in Va. to require hospital sale.
    Burda D
    Mod Healthc; 1995 Sep; 25(36):32. PubMed ID: 10145160
    [No Abstract]   [Full Text] [Related]  

  • 80. COPAing with antitrust rules. Just three systems have used certificates of public advantage seeking antitrust immunity. Experts now say they're regulatory dinosaurs.
    Taylor M
    Mod Healthc; 2005 Feb; 35(8):30-2, 34. PubMed ID: 15765844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.